We determined the progression of LV thickness and its association with ECG, biomarkers and symptoms in untreated wild-type transthyretin cardiac amyloidosis (ATTR-CA wt). Measurements were made on 2 echocardiograms, at… Click to show full abstract
We determined the progression of LV thickness and its association with ECG, biomarkers and symptoms in untreated wild-type transthyretin cardiac amyloidosis (ATTR-CA wt). Measurements were made on 2 echocardiograms, at least 18 months apart, before and after the diagnostic Tc-99m pyrophosphate (PYP
               
Click one of the above tabs to view related content.